Korys

Total investments

41

Average round size

17M

Portfolio companies

29

Rounds per year

1.78

Lead investments

14

Follow on index

0.29

Exits

7

Stages of investment
SeedPrivate EquityLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareEnergyRenewable EnergySolarEnergy EfficiencyClean EnergyWind Energy

Summary

Korys appeared to be the VC, which was created in 2011. The leading representative office of defined VC is situated in the Huizingen. The venture was found in Europe in Belgium.

We also calculated 8 valuable employees in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Korys, startups are often financed by PMV, Gilde Healthcare, Van Herk Ventures. The meaningful sponsors for the fund in investment in the same round are PMV, Debiopharm Group, Beringea. In the next rounds fund is usually obtained by PMV Tina Fund, Johnson & Johnson Development Corporation, EASME - EU Executive Agency for SMEs.

The higher amount of exits for fund were in 2016. Comparing to the other companies, this Korys performs on 8 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 38 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity.

For fund there is no match between the location of its establishment and the land of its numerous investments - The Netherlands. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Renewable Energy. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline Agendia, Amphivena Therapeutics, Greenbyte AB

Show more

Investments analytics

Analytics

Total investments
41
Lead investments
14
Exits
7
Rounds per year
1.78
Follow on index
0.29
Investments by industry
  • Renewable Energy (11)
  • Biotechnology (10)
  • Information Technology (10)
  • Energy (9)
  • Energy Efficiency (6)
  • Show 58 more
Investments by region
  • Netherlands (10)
  • Belgium (13)
  • United States (3)
  • United Kingdom (2)
  • Switzerland (1)
  • Show 5 more
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
41M
Group Appearance index
0.73
Avg. company exit year
9
Avg. multiplicator
0.88
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Sensorfact 19 Jul 2023 Information Technology, Energy, Energy Efficiency Early Stage Venture 29M Utrecht, Utrecht, Netherlands
VoltStorage 30 Jul 2021 Energy Storage, Electronics, Energy, Renewable Energy, Clean Energy, Battery, Energy Management Early Stage Venture 11M Munich, Bavaria, Germany

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.